Home About us Board of Directors Supporters Programs and Events Contact us News and Media   
Case #1—Evaluating prognostic tools in early breast cancer
Pugliano View Webcast View Slides

Fellow presenter: Lina Pugliano, MD

Lina Pugliano, MD
Institut Jules Bordet
Brussels, Belgium

Sotiriou View Webcast View Slides

Faculty discussant: Christos Sotiriou, MD, PhD

Christos Sotiriou, MD, PhD
Institut Jules Bordet
Brussels, Belgium

Case #2—Challenges in endocrine-responsive metastatic breast cancer: Overcoming resistance to endocrine therapy
Lynch View Webcast View Slides

Fellow presenter: Siobhan Lynch, MD

Siobhan Lynch, MD
The University of Texas
M. D. Anderson Cancer Center
Houston, Texas, United States

Gonzalez View Webcast View Slides

Faculty discussant: Ana Maria Gonzalez-Angulo, MD, MSc, FACP

Ana Maria Gonzalez-Angulo, MD, MSc, FACP
The University of Texas
M. D. Anderson Cancer Center
Houston, Texas, United States

Case #3—Inflammatory breast cancer: Treatment strategies in early-stage disease
Albany View Webcast View Slides

Fellow presenter: Costatine Albany, MD

Costatine Albany, MD
Indiana University
Melvin and Bren Simon Cancer Center
Indianapolis, Indiana, United States

Miller View Webcast View Slides

Faculty discussant: Kathy Miller, MD

Kathy Miller, MD
Indiana University
Melvin and Bren Simon Cancer Center
Indianapolis, Indiana, United States

Case #4—Brain metastases in HER2-positive breast cancer: Challenges and opportunities
Luis View Webcast View Slides

Fellow presenter: Inês Luís, MD

Inês Luís, MD
Dana-Farber Cancer Institute
Boston, Massachusetts, United States

Lin View Webcast View Slides

Faculty discussant: Nancy Lin, MD

Nancy Lin, MD
Dana-Farber Cancer Institute
Boston, Massachusetts, United States

Case #5—Metastatic triple-negative breast cancer: A dilemma in search of practical solutions
Jhaveri View Webcast View Slides

Fellow presenter: Komal Jhaveri, MD

Komal Jhaveri, MD
Memorial Sloan-Kettering Cancer Center
New York, New York, United States

DiLeo View Webcast View Slides

Faculty discussant: Angelo Di Leo, MD, PhD

Angelo Di Leo, MD, PhD
Hospital of Prato
Istituto Toscano Tumori
Prato, Italy

Support for this educational activity is provided by the Breast Cancer Research Foundation and the European School of Oncology.